Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ).
Extrawell Pharmaceutical Holdings Limited has announced a change regarding the proposed appointment of an auditor and the special general meeting. The company has decided to cancel the previously announced book closure period, allowing shareholders to transfer shares until 27 March 2025 to be eligible to attend and vote at the meeting. This decision reflects the company’s commitment to ensuring shareholder participation and transparency in its governance processes.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited is a company incorporated in Bermuda, operating in the pharmaceutical industry. The company is involved in the development, manufacturing, and distribution of pharmaceutical products, focusing on enhancing healthcare solutions.
YTD Price Performance: -10.0%
Average Trading Volume: 1,328,518
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$105.2M
See more insights into 0858 stock on TipRanks’ Stock Analysis page.